FdaApplication
ANDA 219952
Identifiers
- fda_app_no: ANDA219952
Properties
| Property | Value |
|---|---|
| applicant_name | SCIEGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2026-07-01 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BRIVARACETAM | BRIVARACETAM | 50MG | TABLET;ORAL |
| BRIVARACETAM | BRIVARACETAM | 100MG | TABLET;ORAL |
| BRIVARACETAM | BRIVARACETAM | 10MG | TABLET;ORAL |
| BRIVARACETAM | BRIVARACETAM | 25MG | TABLET;ORAL |
| BRIVARACETAM | BRIVARACETAM | 75MG | TABLET;ORAL |
5 products